# GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE
> **ANDA216082** · Abbreviated New Drug Application (Generic) · Sponsor: GRANULES · Approved 2022-08-22
## Drug
- **FDA Application Number:** ANDA216082
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE
- **Generic name:** GUAIFENESIN AND PSEUDOEPHEDRINE HCL
- **Active ingredients:** GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** GRANULES
- **Manufacturer:** Granules India Ltd
- **First approval:** 2022-08-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216082)
---
*AI Analytics · CC0 1.0*